QSA Appoints Bruce Lynn as the Chief Executive Officer
Queen Square Analytics announces the appointment of Bruce Lynn as CEO of the company. Lynn supported the formation of the company advising its founder in its business planning stage.
Lynn is a 30-year veteran of the software industry having built a range of businesses including Kenan Systems UK, Microsoft UK digital technology, and Red Bee Piero. Most recently he has been working in the medical imaging sector with a number of organisations including Brandon Medical, Enteric HTC, Motilent, Forclarity. Lynn previously held the position of CEO for another UCL med-tech spin-out, SmartTarget (which was sold to Intuitive Fusion).
“Medical imaging technology has surged in use over the past decade providing a wealth of data for better understanding and treating conditions. The mountain of digital data not only present huge opportunity, but also complex challenges to navigate and interpret. Queen Square Analytics assembles a team of world class expertise in this area who can assist to best analyse this large data sets and draw insights, often in the context of clinical trials.”, Bruce Lynn commented.
“Bruce brings the business acumen to our world-leading academic expertise at UCL to deliver impact in global multiple sclerosis (MS) clinical trials through QSA. We look forward to working with Bruce at the cutting edge of the latest innovations for medical imaging to ultimately improve lives of those living with devastative neurological disorders such as MS anywhere in the world. “ Arman Eshaghi, co-founder of QSA, commented.